Targeting CDK12 to treat DM1

被引：0
|
作者：
Sarah Crunkhorn [ ]
机构：
来源：
Nature Reviews Drug Discovery | 2020年 / 19卷 / 6期
关键词：
D O I：
10.1038/d41573-020-00086-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：388 / 388
相关论文
共 50 条
  • [1] Research progress of anticancer drugs targeting CDK12
    Yan, Zhijia
    Du, Yongli
    Zhang, Haibin
    Zheng, Yong
    Lv, Huiting
    Dong, Ning
    He, Fang
    RSC MEDICINAL CHEMISTRY, 2023, 14 (09): : 1629 - 1644
  • [2] Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer
    Hamman, Kristin
    Bradley, Michael
    Marineau, Jason
    Choi, Yoon
    Malojcic, Goran
    Orlando, David
    Ren, Yixuan
    Ke, Nan
    Hu, Shanhu
    Olson, Eric
    Fritz, Christian
    Roberts, Christopher
    FASEB JOURNAL, 2017, 31
  • [3] Targeting the transcriptional kinases CDK12 and CDK13 in breast and ovarian cancer
    Bradley, Michael
    Marineau, Jason
    Choi, Yoon
    Hamman, Kristin
    Malojcic, Goran
    Orlando, David
    Ren, Yixuan
    Ke, Nan
    Hu, Shanhu
    Olson, Eric
    Fritz, Christian
    Roberts, Christopher
    CANCER RESEARCH, 2017, 77
  • [4] Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery
    Liu, Hui
    Liu, Kangdong
    Dong, Zigang
    CANCER RESEARCH, 2021, 81 (01) : 18 - 26
  • [5] Therapeutic Targeting of CDK12/CDK13 in Triple-Negative Breast Cancer
    Quereda, Victor
    Bayle, Simon
    Vena, Francesca
    Frydman, Sylvia M.
    Monastyrskyi, Andrii
    Roush, William R.
    Duckett, Derek R.
    CANCER CELL, 2019, 36 (05) : 545 - +
  • [6] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Zhang, Tinghu
    Kwiatkowski, Nicholas
    Olson, Calla M.
    Dixon-Clarke, Sarah E.
    Abraham, Brian J.
    Greifenberg, Ann K.
    Ficarro, Scott B.
    Elkins, Jonathan M.
    Liang, Yanke
    Hannett, Nancy M.
    Manz, Theresa
    Hao, Mingfeng
    Bartkowiak, Bartlomiej
    Greenleaf, Arno L.
    Marto, Jarrod A.
    Geyer, Matthias
    Bullock, Alex N.
    Young, Richard A.
    Gray, Nathanael S.
    NATURE CHEMICAL BIOLOGY, 2016, 12 (10) : 876 - +
  • [7] Covalent targeting of remote cysteine residues to develop CDK12 and CDK13 inhibitors
    Tinghu Zhang
    Nicholas Kwiatkowski
    Calla M Olson
    Sarah E Dixon-Clarke
    Brian J Abraham
    Ann K Greifenberg
    Scott B Ficarro
    Jonathan M Elkins
    Yanke Liang
    Nancy M Hannett
    Theresa Manz
    Mingfeng Hao
    Bartlomiej Bartkowiak
    Arno L Greenleaf
    Jarrod A Marto
    Matthias Geyer
    Alex N Bullock
    Richard A Young
    Nathanael S Gray
    Nature Chemical Biology, 2016, 12 : 876 - 884
  • [8] Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
    Zeng, Mei
    Kwiatkowski, Nicholas P.
    Zhang, Tinghu
    Nabet, Behnam
    Xu, Mousheng
    Liang, Yanke
    Quan, Chunshan
    Wang, Jinhua
    Hao, Mingfeng
    Palakurthi, Sangeetha
    Zhou, Shan
    Zeng, Qing
    Kirschmeier, Paul T.
    Meghani, Khyati
    Leggett, Alan L.
    Qi, Jun
    Shapiro, Geoffrey I.
    Liu, Joyce F.
    Matulonis, Ursula A.
    Lin, Charles Y.
    Konstantinopoulos, Panagiotis A.
    Gray, Nathanael S.
    ELIFE, 2018, 7
  • [9] The emerging roles of CDK12 in tumorigenesis
    Paculova, Hana
    Kohoutek, Jiri
    CELL DIVISION, 2017, 12
  • [10] The emerging roles of CDK12 in tumorigenesis
    Hana Paculová
    Jiří Kohoutek
    Cell Division, 12
12345